ARTICLE | Clinical News
Oncaspar pegaspargase regulatory update
December 7, 2015 8:00 AM UTC
EMA’s CHMP recommended approval of Oncaspar pegaspargase from Baxalta to treat acute lymphoblastic leukemia (ALL) in patients of all ages in combination with antineoplastic therapy. In July, Baxalta p...